Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines.
about
Adrenocortical carcinoma: the management of metastatic disease.Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas.Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancerCushing's syndrome: an update on current pharmacotherapy and future directions.Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma.Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.
P2860
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cytotoxic activity of gemcitab ...... cortical carcinoma cell lines.
@en
Cytotoxic activity of gemcitab ...... cortical carcinoma cell lines.
@nl
type
label
Cytotoxic activity of gemcitab ...... cortical carcinoma cell lines.
@en
Cytotoxic activity of gemcitab ...... cortical carcinoma cell lines.
@nl
prefLabel
Cytotoxic activity of gemcitab ...... cortical carcinoma cell lines.
@en
Cytotoxic activity of gemcitab ...... cortical carcinoma cell lines.
@nl
P2093
P50
P1476
Cytotoxic activity of gemcitab ...... cortical carcinoma cell lines.
@en
P2093
Alfredo Berruti
Marco Volante
Mauro Papotti
Sonia Carturan
P356
10.1016/J.MCE.2013.08.023
P577
2013-09-07T00:00:00Z